Class   536	ORGANIC COMPOUNDS -- PART OF THE CLASS 532-570 SERIES
	Click here to view a PDF version of this file

This Class 536 is considered to be an integral part of Class 260 (see the Class 260 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 260.

ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

1.11

. (1 indent ) Carbohydrates or derivatives

2

.. (2 indent ) Pectin or derivative

3

.. (2 indent ) Algin or derivative

4.1

.. (2 indent ) O- or S- Glycosides

4.4

... (3 indent ) Aescin or derivative

5

... (3 indent ) Cyclopentanohydrophenanthrene ring system

6

.... (4 indent ) Oxygen containing six-membered hetero ring (e.g., oxathiane, etc.)

6.1

.... (4 indent ) Oxygen containing five-membered hetero ring

6.2

....• (5 indent ) Nitrogen, phosphorus or halogen containing

6.3

....• (5 indent ) Processes of extracting from plant materials

6.4

... (3 indent ) Daunomycin or derivative

6.5

... (3 indent ) Oxygen containing hetero ring having at least twenty members (e.g., amphotericin, nystatin, pimaricin, etc.)

7.1

... (3 indent ) Oxygen containing hetero ring having 12-19 members (e.g., methymycin, carbomycin, spiramycin, etc.)

7.2

.... (4 indent ) Erythromycin or derivative (e.g., oleandomycin, etc.)

7.3

....• (5 indent ) Boron, phosphorus or sulfur containing

7.4

....• (5 indent ) Additional nitrogen containing

7.5

....• (5 indent ) Purification or recovery

8

... (3 indent ) Flavon sugar compounds

8.8

... (3 indent ) Coumermycin or derivative

13

... (3 indent ) Novobiocin or derivative

13.1

... (3 indent ) Antibiotic BM 123 or derivative

13.2

... (3 indent ) Neomycin B or neomycin C or derivative

13.3

... (3 indent ) Paromomycin or derivative (e.g., neomycin E, etc.)

13.4

... (3 indent ) Antibiotic XK or derivative

13.5

... (3 indent ) Butirosin or derivative (e.g., ambutyrosin, etc.)

13.6

... (3 indent ) Gentamicin or derivative

13.7

... (3 indent ) Kanamycin or derivative

13.8

.... (4 indent ) Carbonyl bonded directly to kanamycin nitrogen

13.9

... (3 indent ) Sisomicin or derivative

14

... (3 indent ) Streptomycin or derivative

15

.... (4 indent ) Dihydrostreptomycin or derivative

16

.... (4 indent ) Addition compounds

16.1

... (3 indent ) Fortimicin or derivative

16.2

... (3 indent ) Lincomycin or derivative

16.3

.... (4 indent ) Cyano or -COO- containing

16.4

.... (4 indent ) Additional sulfur containing

16.5

.... (4 indent ) Phosphorus or halogen containing

16.6

... (3 indent ) Neamine or derivative (e.g., neomycin A, etc.)

16.7

... (3 indent ) Kasugamycin or derivative

16.8

... (3 indent ) Antibiotics

16.9

.... (4 indent ) Purification or recovery

17.1

... (3 indent ) Boron, phosphorus, heavy metal or aluminum containing

17.2

... (3 indent ) Nitrogen containing

17.3

.... (4 indent ) Nitrogen containing hetero ring

17.4

....• (5 indent ) Nitrogen in aglycone moiety

17.5

.... (4 indent ) Sulfur containing (e.g., methylthiolincosaminide, etc.)

17.6

....• (5 indent ) Nitrogen or sulfur in aglycone moiety

17.7

.... (4 indent ) Nitro or nitroso containing

17.8

....• (5 indent ) Nitrogen in aglycone moiety

17.9

.... (4 indent ) Nitrogen in aglycone moiety

18.1

... (3 indent ) Polycyclo ring system (e.g., hellebrin, etc.)

18.2

... (3 indent ) Containing -C(=X)X- wherein the X's are the same or diverse chalcogens

18.3

... (3 indent ) Plural oxyalkylene groups bonded directly to each other

18.4

... (3 indent ) Halogen containing

18.5

... (3 indent ) Processes

18.6

.... (4 indent ) Reacting a carbohydrate with an organic -O- containing compound (e.g., reacting glucose with methanol, etc.)

18.7

.. (2 indent ) Nitrogen containing

20

... (3 indent ) Chitin or derivative

21

... (3 indent ) Heparin or derivative

22.1

... (3 indent ) N-glycosides, polymers thereof, metal derivatives (e.g., nucleic acids, oligonucleotides, etc.)

23.1

.... (4 indent ) DNA or RNA fragments or modified forms thereof (e.g., genes, etc.)

23.2

....• (5 indent ) Encodes an enzyme

23.4

....• (5 indent ) Encodes a fusion protein

23.5

....• (5 indent ) Encodes an animal polypeptide

23.51

....•. (6 indent ) Hormone

23.52

....•. (6 indent ) Interferon

23.53

....•. (6 indent ) Immunoglobulin

23.6

....• (5 indent ) Encodes a plant polypeptide

23.7

....• (5 indent ) Encodes a microbial polypeptide

23.71

....•. (6 indent ) Bacillus thuringiensis insect toxin

23.72

....•. (6 indent ) Viral protein

23.74

....•. (6 indent ) Fungal protein

24.1

....• (5 indent ) Non-coding sequences which control transcription or translation processes (e.g., promoters, operators, enhancers, ribosome binding sites, etc.)

24.2

....• (5 indent ) Non-coding sequences having no known regulatory function which are adaptors or linkers for vector or gene contruction

24.3

....• (5 indent ) Probes for detection of specific nucleotide sequences or primers for the synthesis of DNA or RNA

24.31

....•. (6 indent ) Probes for detection of animal nucleotide sequences

24.32

....•. (6 indent ) Probes for detection of microbial nucleotide sequences

24.33

....•. (6 indent ) Primers

24.5

....• (5 indent ) Nucleic acid expression inhibitors

25.1

.... (4 indent ) 3`-5` linked RNA

25.2

.... (4 indent ) 2`-5` linked RNA

25.3

.... (4 indent ) Synthesis of polynucleotides or oligonucleotides

25.31

....• (5 indent ) Deprotection step

25.32

....• (5 indent ) Labels or markers utilized (e.g., radiotracer, affinity, fluoroescent, phosphorescent, markers, etc.)

25.33

....• (5 indent ) Pentavalent phosphorus compound utilized

25.34

....• (5 indent ) Trivalent phosphorus compound utilized

25.4

.... (4 indent ) Separation or purification of polynucleotides or oligonucleotides

25.41

....• (5 indent ) Extraction processes (e.g., solvent extraction process, etc.)

25.42

....•. (6 indent ) Denaturant utilized

25.5

.... (4 indent ) Homopolymers having repeating sequences of four or more identical nucleotide units

25.6

.... (4 indent ) Nucleic acids which include two or three nucleotide units

26.1

.... (4 indent ) Phosphorus containing N-glycoside wherein the N is part of an N-hetero ring

26.11

....• (5 indent ) The phosphorus is part of a ring

26.12

....•. (6 indent ) The N-hetero ring is part of a purine ring system

26.13

....•.. (7 indent ) Adenine or substituted adenine

26.14

....•. (6 indent ) The N-hetero ring is a diazine or a diazole ring, including hydrogenated

26.2

....• (5 indent ) Plural phosphorus atoms in N-glycoside

26.21

....•. (6 indent ) Plural phosphorus atoms bonded directly to the same chalcogen in a chain (e.g., pyrophosphates, polyanhydrides of phosphorus acids, etc.)

26.22

....•.. (7 indent ) Both terminal phosphorus atoms are esterified by organic groups wherein one of these organic groups is the sugar moiety

26.23

....•... (8 indent ) Exactly two phosphorus atoms in the chain (e.g., coenzyme A, etc.)

26.24

....•.... (9 indent ) NAD (nicotinamide adenine dinucleotide) and derivatives thereof

26.25

....•.... (9 indent ) FAD (flavin adenine dinucleotide) and derivatives thereof

26.26

....•.. (7 indent ) Triphosphates (in same chain)

26.3

....•. (6 indent ) Plural monophosphate groups (e.g., adenosine-3`, 5`-biscarboxymethyl phosphonate, cytidine nucleoside diphosphate, etc.)

26.4

....• (5 indent ) Cobalamin nucleotides (e.g., vitamin B-12, etc.)

26.41

....•. (6 indent ) Processes of preparing or labelling

26.42

....•. (6 indent ) Processes of concentraction, separation, recovery, or extraction (e.g., recovery from organ extracts, from fermentation broth, from sewage sludge, etc.)

26.43

....•.. (7 indent ) Adsorbent used (e.g., activated alumina, ion exchange resins, etc.)

26.44

....• (5 indent ) Cobalamin analogs (i.e., compounds wherein the benzimidazole ring system has been replaced by another organic ring structure, or compounds wherein cobalt has been removed or replaced by another metal, or is substituted by a group other than -OH or -CN)

26.5

....• (5 indent ) Plural N-glycosidic moieties bonded to the same phosphorus ester group

26.6

....• (5 indent ) Labelled (e.g., tagged with radioactive tracer, fluorescent marker, intercalator, etc.)

26.7

....• (5 indent ) The N-hetero ring is part of a bicyclic ring system

26.71

....•. (6 indent ) Preparing purine nucleotides

26.72

....•.. (7 indent ) Guanosine nucleotide preparation

26.73

....•. (6 indent ) Separation or purification of purine nucleotides

26.74

....•. (6 indent ) Inosine nucleotide

26.8

....• (5 indent ) The N-hereto ring is six-membered and monocyclic (e.g., uridine-5`-mono- phosphate, etc.)

26.9

....• (5 indent ) The N-hereto ring is five-membered (e.g., 1- -D-riboburanosyl-1, 2,3- triazole-4-carboxamide-5`-phosphate, etc.)

27.1

.... (4 indent ) N-glycosides wherein the N is part of an N-hetero ring which hetero ring is part of a polycyclo ring system containing an N-hetero ring and an additional hetero ring (e.g., rebeccamycin, etc.)

27.11

....• (5 indent ) Preparing by cleaving nucleic acids or by attaching an N-heterocyclic base to a sugar ring

27.12

....• (5 indent ) Separation or purification (e.g., resolving isomeric mixtures, etc.)

27.13

....• (5 indent ) Bicyclic ring system consisting of the N-hetero ring fused to another hetero ring (e.g., 2-azaadenines, 6-azaadenines, etc.)

27.14

....•. (6 indent ) Multideoxy or didehydro

27.2

....•. (6 indent ) The bicyclic ring system consists of a 1,3-diazine ring, which may be hydrogenated, fused to a five-membered N-hetero ring (e.g., purine isoesters like tubercidin, toyocamycin, sangivamycin, sparsomycin A, etc.)

27.21

....•.. (7 indent ) The five-membered N-hetero ring is 1,3-diazole, which may be hydrogenated (e.g., 6-chloropurine nucleoside, nebularin, etc.)

27.22

....•... (8 indent ) Carbonyl, thiocarbonyl, or nitrogen, other than as nitro or nitroso, bonded directly to the sugar ring

27.23

....•... (8 indent ) Carbonyl, thiocarbonyl, additional hetero ring or nitrogen, other than as nitro or nitroso, attached indirectly to the sugar ring by acyclic nonionic bonding

27.3

....•.... (9 indent ) Adenosyl

27.31

....•....• (10 indent ) S-Adenosyl-L-methionine, S-Adenosyl-L-homocysteine, salts, or esters thereof

27.4

....•... (8 indent ) Arabinose is sugar moiety

27.5

....•... (8 indent ) Ketose is sugar moiety (e.g., decoyinine, psicofuranosylpurines, etc.)

27.6

....•... (8 indent ) Nitrogen, other than nitro or nitroso, bonded directly to the 6-position of a purine ring system (e.g., adenosine, etc.)

27.61

....•.... (9 indent ) Additional nitrogen bonded directly to the 2-position of the purine ring system

27.62

....•.... (9 indent ) Nitrogen, chalcogen, or additional carbon bonded directly to the 6-position nitrogen (e.g., 6-position nitrogen is substituted, etc.)

27.63

....•....• (10 indent ) Halogen, chalcogen, or cyano bonded directly to the 2-position of the purine ring system

27.7

....•.... (9 indent ) Chalcogen, halogen, or benzene bonded directly to carbon of the purine ring system (e.g., isoguanosine, 2-fluoroadenosine, etc.)

27.8

....•... (8 indent ) Chalcogen bonded directly to the 6- or 2-position of a purine ring system (e.g., inosine, etc.)

27.81

....•.... (9 indent ) Nitrogen, other than nitro or nitroso, bonded directly to the 2-position of the purine ring system (e.g., guanosine, etc.)

28.1

.... (4 indent ) N-glycosides wherein the N is part of a six-membered hetero ring (e.g., diazines, etc.)

28.2

....• (5 indent ) Multideoxy or didehydro

28.3

....• (5 indent ) The N-hetero ring is a triazine ring, including hydrogenated (e.g., 6-azauridine, etc.)

28.4

....• (5 indent ) The N-hetero ring is a 1,3-diazine ring, including hydrogenated (e.g., pyrimidines, etc.)

28.5

....•. (6 indent ) Nitrogen, other than nitro or nitroso, bonded directly to the 4-position, and chalcogen bonded directly to the 2-position of the diazine ring (e.g., cytidines, etc.)

28.51

....•.. (7 indent ) Having chalcogen, carbonyl, or thiocarbonyl bonded directly to the 4-position substituent nitrogen

28.52

....•.. (7 indent ) Halogen or alkyl group of 1-5 carbon atoms bonded directly to the 5-position of the diazine ring

28.53

....•. (6 indent ) Chalcogen bonded directly to the 2- and 4-positions of the diazine ring (e.g., uridine, etc.)

28.54

....•.. (7 indent ) Alkyl, or substituted alkyl, bonded directly to the 5-position of the diazine ring (e.g., thymidine, 5-methyl uridine, etc.)

28.55

....•.. (7 indent ) Halogen bonded directly to the 5-position of the diazine ring (e.g., 5-fluorouridine, etc.)

28.6

.... (4 indent ) N-glycosides wherein the N is part of a five-membered hetero ring (e.g., selenazole nucleosides, pyrrole nucleosides, etc.)

28.7

....• (5 indent ) Plural nitrogens in the N-hetero ring (e.g., triazoles, etc.)

28.8

....•. (6 indent ) The N-hetero ring is a 1,3-diazole ring, including hydrogenated (e.g., imidazoles, etc.)

28.9

....•.. (7 indent ) Benzimidazoles

29.1

.... (4 indent ) Nitrogen of N-glycoside is acyclic nitrogen

29.11

....• (5 indent ) N-hetero ring bonded directly or indirectly to the acyclic nitrogen

29.12

....• (5 indent ) The acyclic nitrogen is part of a urea or thiourea group

29.13

....• (5 indent ) Sulfur containing (e.g., sulfides, sulfones, sulfates, sulfonamides, etc.)

29.2

... (3 indent ) C-glycosides wherein the sugar ring is bonded directly to carbon of an N-hetero ring (e.g., 9-deazaadenosines, etc.)

30

... (3 indent ) Cellulose derivatives

31

.... (4 indent ) Nitrogen containing hetero ring (e.g., morpholine, etc.)

32

.... (4 indent ) Esters

33

....• (5 indent ) Sulfur containing acid

34

....• (5 indent ) Phosphorus containing acid

35

....• (5 indent ) Nitrates

36

....•. (6 indent ) Mixed esters

37

....•. (6 indent ) With pretreatment process

38

....•. (6 indent ) Subsequent treatment process

39

....•.. (7 indent ) Comminuting

40

....•.. (7 indent ) Recovery from photographic film

41

....•.. (7 indent ) Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

42

....•.. (7 indent ) Stabilizing

43

.... (4 indent ) Ethers

44

....• (5 indent ) Mixed ethers

45

... (3 indent ) Starch derivatives

46

.... (4 indent ) Dextrin derivatives

47

.... (4 indent ) Cross-linked

48

.... (4 indent ) Esters

49

....• (5 indent ) Ether-esters or mixed esters

50

.... (4 indent ) Ethers

51

... (3 indent ) Dextran derivatives

52

... (3 indent ) Gum derivatives

53

... (3 indent ) Oxygen double bonded and nitrogen bonded directly to the same carbon

54

... (3 indent ) Sulfur containing

55

... (3 indent ) Plural nitrogens containing

55.1

.... (4 indent ) Polysaccharides

55.2

... (3 indent ) Glucosamine containing

55.3

... (3 indent ) Processes

56

.. (2 indent ) Cellulose or derivative

57

... (3 indent ) Regenerated cellulose

58

... (3 indent ) Esters

59

.... (4 indent ) Sulfur containing acid

60

....• (5 indent ) Xanthate or viscose

61

....•. (6 indent ) Subsequent treatment process

62

.... (4 indent ) Phosphorus containing acid

63

.... (4 indent ) Carboxylic acid esters

64

....• (5 indent ) Mixed carboxylate esters

65

....•. (6 indent ) Propionate, butyrate or isobutyrate containing

66

....• (5 indent ) Ether-esters

67

....• (5 indent ) Formates

68

....• (5 indent ) Propionates, butyrates or isobutyrates

69

....• (5 indent ) Acetates

70

....•. (6 indent ) With pretreatment process

71

....•.. (7 indent ) Acetic acid utilized in pretreatment

72

....•... (8 indent ) Halogen containing compound utilized in process

73

....•... (8 indent ) Sulfur containing compound utilized in pretreatment

74

....•.. (7 indent ) Sulfur containing compound utilized in pretreatment

75

....•.. (7 indent ) Halogen containing compound utilized in process

76

....•. (6 indent ) Subsequent treatment process

77

....•.. (7 indent ) Comminuting or centrifuging

78

....•.. (7 indent ) Recovery from photographic film

79

....•.. (7 indent ) Corrosiveness reduced

80

....•.. (7 indent ) Viscosity or degree of polymerization changed (e.g., degrading, cross linking, etc.)

81

....•.. (7 indent ) Stabilizing

82

....•.. (7 indent ) Halogen containing compound utilized in process

83

....•. (6 indent ) Halogen containing compound utilized in process

84

... (3 indent ) Ethers

85

.... (4 indent ) Subsequent treatment process

86

....• (5 indent ) Comminuting

87

....• (5 indent ) Liquid interaction properties changed (e.g., solubility, absorbability, etc.)

88

....• (5 indent ) Viscosity, degree of polymerization or heat stability changed (e.g., degrading, cross-linking, etc.)

89

....• (5 indent ) Acid employed in subsequent treatment

90

.... (4 indent ) Mixed ethers

91

....• (5 indent ) Hydroxyalkyl containing

92

.... (4 indent ) Sulfur containing

93

.... (4 indent ) Unsaturated

94

....• (5 indent ) Aromatic nucleus containing

95

.... (4 indent ) Hydroxyalkyl containing

96

....• (5 indent ) Hydroxyethyl

97

.... (4 indent ) Carboxyalkyl or salts thereof

98

....• (5 indent ) Carboxymethyl or salts thereof

99

.... (4 indent ) Alkyl or cycloalkyl

100

....• (5 indent ) Ethyl

101

... (3 indent ) Metal containing

102

.. (2 indent ) Starch or derivative

103

... (3 indent ) Dextrin or derivative

104

... (3 indent ) Aldehyde reaction product

105

... (3 indent ) Oxidized starch or derivative

106

... (3 indent ) Cross-linked

107

... (3 indent ) Esters

108

.... (4 indent ) Ether-esters or mixed esters

109

.... (4 indent ) Phosphorus or sulfur containing

110

.... (4 indent ) Carboxylic

111

... (3 indent ) Ethers

112

.. (2 indent ) Dextran or derivative

113

... (3 indent ) Iron containing

114

.. (2 indent ) Gums or derivatives

115

.. (2 indent ) Esters

116

... (3 indent ) Ether-esters

117

... (3 indent ) Phosphorus containing

118

... (3 indent ) Sulfur containing

119

... (3 indent ) Carboxylic

120

.. (2 indent ) Ethers

121

.. (2 indent ) Metal containing

122

.. (2 indent ) Sulfur or halogen containing

123

.. (2 indent ) Plural diverse saccharides containing (e.g., hetero polysaccharides, etc.)

123.1

.. (2 indent ) Polysaccharides

123.12

... (3 indent ) Glucans (e.g., pullulan, etc.)

123.13

... (3 indent ) Disaccharides (e.g., maltose, sucrose, lactose, formaldehyde lactose, etc.)

124

.. (2 indent ) Processes

125

... (3 indent ) Isomerization

126

... (3 indent ) Polymerization

127

... (3 indent ) Purification or recovery

128

.... (4 indent ) From plant material

	FOREIGN ART COLLECTIONS

FOR000

CLASS-RELATED FOREIGN DOCUMENTS

   Note: Some content linked to on this page may require a plug-in for Adobe Acrobat Reader.

This file produced by USPTO - SIRA - Office of Patent Automation - ReferenceTools Project. Questions or comments relating to this file should be directed to Patent Automation Feedback.